Buscar
Mostrando ítems 1-10 de 102
Analysis by MRI of Residual Tumor After Radiofrequency Ablation for Early Stage Breast Cancer
(AMER ROENTGEN RAY SOCRESTON, 2012)
OBJECTIVE. The objective of our study was to evaluate the effectiveness of MRI in the detection of possible residual lesions after radiofrequency ablation (RFA) in the treatment of breast cancer. SUBJECTS AND METHODS. We ...
Analysis by MRI of Residual Tumor After Radiofrequency Ablation for Early Stage Breast Cancer
(Amer Roentgen Ray Soc, 2012-03-01)
OBJECTIVE. the objective of our study was to evaluate the effectiveness of MRI in the detection of possible residual lesions after radiofrequency ablation (RFA) in the treatment of breast cancer.SUBJECTS and METHODS. We ...
Magnetization transfer ratio as a predictor of malignancy in breast lesions: Preliminary results
(JOHN WILEY & SONS INC, 2008)
MRI is an important tool for investigating breast cancer. Although recognized as the method of choice for screening highrisk patients, and for other indications the role of MRI for lesion characterization remains controversial. ...
Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
(Springer, 2021)
OBJECTIVE: To evaluate the impact of preoperative MRI in the management of Ductal carcinoma in situ (DCIS). METHODS: We searched the PubMed, EMBASE and Cochrane Library databases to identify randomised clinical trials ...
Breast imaging: is the sonographic descriptor of orientation valid for magnetic resonance imaging?
(WILEY-BLACKWELLHOBOKEN, 2012)
Purpose: To evaluate if the Breast Imaging Reporting and Data System (BI-RADS) ultrasound descriptor of orientation can be used in magnetic resonance imaging (MRI). Materials and Methods: We conducted a retrospective study ...
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells
(Taylor & Francis, 2015-03)
In this work the selective uptake of native horse spleen ferritin and apoferritin loaded with MRI contrast agents has been assessed in human breast cancer cells (MCF-7 and MDA-MB-231). The higher expression of L-ferritin ...
Ferritin Decorated PLGA/Paclitaxel Loaded Nanoparticles Endowed with an Enhanced Toxicity Toward MCF-7 Breast Tumor Cells
(American Chemical Society, 2017-03)
PolyLactic and Glycolic Acid nanoparticles (PLGA-NPs), coated with L-Ferritin,are exploited for the simultaneous delivery of paclitaxel and an amphiphilic Gd based MRI contrast agent into breast cancer cells (MCF7). ...